Jazz Pharmaceuticals PLC (JAZZ) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $188.97
• Market Cap: $11.96B
• EPS: $-6.16
• 52-Week High: $197.47
• 52-Week Low: $95.49

Market Sentiment

Jazz Pharmaceuticals PLC currently has a Bullish sentiment score of 0.28.

About Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC is a prominent biopharmaceutical company dedicated to the development and commercialization of innovative therapies that address pressing unmet medical needs, particularly in neurology, rare diseases, and hematology. Based in Dublin, Ireland, the company operates with a strong global presence, enhancing patient care across the United States and Europe. Jazz's extensive pipeline, coupled with its commitment to research and development, underscores its strategic focus o...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Jazz Pharmaceuticals PLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does JAZZ pay dividends?

Jazz Pharmaceuticals PLC (JAZZ) does not currently pay a regular dividend.

What is JAZZ's market cap?

Jazz Pharmaceuticals PLC (JAZZ) has a market capitalization of $11.96B with a current stock price of $188.97.